Speaker illustration

Doctor Tomoyuki Nagai

Omihachiman community medical center, Omihachiman (Japan)

Member of:

European Society of Cardiology

Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session: Cardio-oncology – Cancer treatment and cardiovascular toxicity

Thumbnail

This platform is supported by

logo Novo Nordisk